Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease (Q41521372)

2 October 2017

Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 October 2017

1 reference

1 reference

Helicobacter pylori infectious disease

inferred from title

1 reference

Yoshio Sumida

1

1 reference

2 October 2017

Kazuyuki Kanemasa

2

1 reference

2 October 2017

Shunsuke Imai

3

1 reference

2 October 2017

Kojiro Mori

4

1 reference

2 October 2017

Saiyu Tanaka

5

1 reference

2 October 2017

Hideto Shimokobe

6

1 reference

2 October 2017

Yoko Kitamura

7

1 reference

2 October 2017

Kohei Fukumoto

8

1 reference

2 October 2017

Akira Kakutani

9

1 reference

2 October 2017

Tomoyuki Ohno

10

1 reference

2 October 2017

Hiroyoshi Taketani

11

1 reference

2 October 2017

Yuya Seko

12

1 reference

2 October 2017

Hiroshi Ishiba

13

1 reference

2 October 2017

Tasuku Hara

14

1 reference

2 October 2017

Akira Okajima

15

1 reference

2 October 2017

Kanji Yamaguchi

16

1 reference

2 October 2017

Michihisa Moriguchi

17

1 reference

2 October 2017

Hironori Mitsuyoshi

18

1 reference

2 October 2017

Kohichiroh Yasui

19

1 reference

2 October 2017

Masahito Minami

20

1 reference

2 October 2017

Yoshito Itoh

21

1 reference

2 October 2017

28 January 2015

1 reference

Journal of Gastroenterology

2 October 2017

1 reference

2 October 2017

50

1 reference

2 October 2017

996-1004

1 reference

2 October 2017

9

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The pathological effect of Helicobacter pylori infection on liver tissues in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Plasma ghrelin following cure of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The association between Helicobacter pylori infection and insulin resistance: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Association of Helicobacter pylori infection with glycemic control in patients with diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter pylori infection increases mucosal permeability of the stomach and intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter species and liver diseases: association or causation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter Pylori infection is a significant risk for modified lipid profile in Japanese male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Helicobacter pylori-related iron deficiency anemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

The effect of helicobacter pylori eradication on liver fat content in subjects with non-alcoholic Fatty liver disease: a randomized open-label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1039-2

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

12 December 2020

Identification of Helicobacter species by 16S rDNA PCR and sequence analysis in human liver samples from patients with various etiologies of benign liver diseases

1 reference

12 December 2020

Detection of Helicobacter pylori in paraffin-embedded specimens from patients with chronic liver diseases, using the amplification method

1 reference

12 December 2020

Pathogenesis of Helicobacter pylori infection

1 reference

12 December 2020

Measurements of iron status in patients with chronic hepatitis

1 reference

12 December 2020

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis in Asia-Oceania

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

12 December 2020

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Influence of Helicobacter pylori infection on iron accumulation in hepatitis C

1 reference

12 December 2020

Impact of Helicobacter pylori eradication on circulating adiponectin in humans

1 reference

12 December 2020

[Helicobacter pylori infection and liver diseases]

1 reference

12 December 2020

Role of hepatic iron in non-alcoholic steatohepatitis

1 reference

12 December 2020

10.1007/S00535-015-1039-2

Identifiers

DOI

1 reference

2 October 2017

1 reference